BG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bunge Global Ltd (BG) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the stock has positive analyst sentiment and some growth potential, the company's recent financial performance shows significant declines in net income, EPS, and gross margin. Additionally, there are no strong proprietary trading signals or recent news catalysts to justify an immediate purchase.
The technical indicators are mixed. The MACD is positive and expanding, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200), suggesting an upward trend. However, the RSI is in the neutral zone at 76.879, and the stock is trading near its resistance level (R1: 121.875). This indicates limited short-term upside potential.
Analysts have raised price targets significantly, with the highest target at $
The Q4 earnings beat expectations, driven by strong performance in Soybean and Other Oilseeds Processing & Refining segments.
Potential synergies from the Viterra merger could drive future growth.
The company's Q4 financials show a sharp decline in net income (-84.22% YoY), EPS (-88.76% YoY), and gross margin (-43.71% YoY).
Uncertainty around biofuel policy could impact future performance.
No significant hedge fund, insider, or congress trading activity to indicate strong institutional confidence.
In Q4 2025, revenue increased significantly by 75.47% YoY to $23.76 billion. However, net income dropped by 84.22% YoY to $95 million, EPS declined by 88.76% YoY to $0.49, and gross margin fell by 43.71% YoY to 4.25%. This indicates that while the company is growing its top line, profitability and efficiency are under pressure.
Analysts are broadly positive on the stock, with multiple firms raising price targets recently. UBS has the highest target at $145, while others like Barclays, BMO Capital, and JPMorgan have targets in the $130-$135 range. Analysts cite strong earnings growth potential, synergies from the Viterra merger, and a demonstrated track record of execution as reasons for their optimism.
